CatalystPit

INSMINSMED Inc

NASDAQ · Pharmaceutical Preparations
Last close $114.14 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
Market cap$24.93B
RECENT INSIDER TRADES
  • 2026-09-11 · Brennan David R (Director) · SELL
  • 2026-08-19 · SHAROKY MELVIN MD (Director) · SELL
  • 2026-08-12 · Adsett Roger (Chief Operating Officer) · SELL
  • 2026-08-12 · Adsett Roger (Chief Operating Officer) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders711
Shares held260,759,068
Value$27.75B
Percent of shares outstanding119.41%
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2026-06-10 · Josh Gottheimer · SELL · $1,001 - $15,000
RECENT NEWS
  • InvestingPro’s fair value spotted Insmed’s 47% drop 10 months early
  • Insmed CFO Sara Bonstein to step down
  • Insmed Announces CFO Transition
  • Goldman Sachs initiates Insmed stock coverage with buy rating, $188 target
  • Insmed: Expensive Stock, But Discount To Recent Highs Makes Bull Case
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
INSMED Inc (INSM) · Stock Price, Insider Trades, Congress Trades · CatalystPit